A study on the detection of circulating tumor cells (CTC) in patients with resected pulmonary metastases from colorectal cancer and its clinical significance as a biomarker
- Conditions
- Pulmonary metastases from colorectal cancer
- Registration Number
- JPRN-UMIN000017460
- Lead Sponsor
- Kawasaki Medical School, Department of General Thoracic Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Not provided
1. History of pulmonary resection or lung radiofrequency ablation (RFA) / radiation therapy at the time of enrollment 2. Serious drug allergy 3. Chest X-ray evidence of interstitial pneumonia or pulmonary fibrosis 4. Any or suspected intercurrent active infection 5. Pregnant women, nursing mothers, possibly pregnant women, and women with no intention of practicing contraception 6. Ongoing continuous treatment with systemic corticosteroid medication 7. Poorly controlled diabetes mellitus or any serious complication such as a cardiac disorder 8. History of active double cancer *Except for malignancies clinically judged to be non-invasive cancer such as carcinoma in situ *Except for malignancies which have not recurred in >5 years after radical treatment 9. Patients likely to be unable to personally give written informed consent and any other condition that the investigator feels would be inadequate for the safe conduct of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CTC positivity rate for patients having undergone resection of PM from CRC
- Secondary Outcome Measures
Name Time Method Relationship of the CTC positivity rate with postoperative recurrence and prognosis